The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of August 12, 2025 in 3D Systems Corporation Lawsuit - DDD

1. Gross Law Firm issues notice for DDD shareholders regarding class action. 2. Allegations include misleading statements and overstated resilience against customer spending. 3. Partnership with United Therapeutics is expected to impact regenerative medicine revenues. 4. Class action deadline for lead plaintiff appointment is August 12, 2025. 5. Shareholders can register to monitor case status and participate at no cost.

Legal

75

5m saved

Insight

Article

FAQ

Why Bearish?

Historical examples show that class action lawsuits often lead to stock price drops. Misleading statements can deteriorate investor trust and impact DDD's valuation.

How important is it?

The lawsuit highlights significant issues within DDD’s financial health and transparency, crucial for investor confidence. Legal challenges can substantially alter investor perceptions.

Why Long Term?

Legal proceedings can take years to resolve, affecting shareholder sentiment and stock value over time. The damages and potential outcomes will likely extend beyond immediate reactions.

Related Companies

UTX PRLB

NEW YORK, June 30, 2025 /PRNewswire/ --

The Gross Law Firm issues the following notice to shareholders of 3D Systems Corporation (NYSE: DDD).

Shareholders who purchased shares of DDD during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery.

CONTACT US HERE: https://securitiesclasslaw.com/securities/3d-systems-corporation-loss-submission-form/?id=154644&from=4

CLASS PERIOD: August 13, 2024 to May 12, 2025

ALLEGATIONS: The complaint alleges that during the class period, Defendants issued materially false and/or misleading statements and/or failed to disclose that: (i) 3D Systems had understated the impact of weakened customer spending on the Company's business, while overstating its resilience in challenging industry conditions; (ii) in addition, the updated milestone criteria in the partnership with United Therapeutics Corporation would negatively impact the Company's regenerative medicine program revenue; and (iii) as a result, the Company's public statements were materially false and misleading at all relevant times.

DEADLINE: August 12, 2025 Shareholders should not delay in registering for this class action. Register your information here: https://securitiesclasslaw.com/securities/3d-systems-corporation-loss-submission-form/?id=154644&from=4

NEXT STEPS FOR SHAREHOLDERS: Once you register as a shareholder who purchased shares of DDD during the timeframe listed above, you will be enrolled in a portfolio monitoring software to provide you with status updates throughout the lifecycle of the case. The deadline to seek to be a lead plaintiff is August 12, 2025. There is no cost or obligation to you to participate in this case.

WHY GROSS LAW FIRM? The Gross Law Firm is a nationally recognized class action law firm, and our mission is to protect the rights of all investors who have suffered as a result of deceit, fraud, and illegal business practices. The Gross Law Firm is committed to ensuring that companies adhere to responsible business practices and engage in good corporate citizenship. The firm seeks recovery on behalf of investors who incurred losses when false and/or misleading statements or the omission of material information by a company lead to artificial inflation of the company's stock. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT: The Gross Law Firm 15 West 38th Street, 12th floor New York, NY, 10018 Email: info@grosslawfirm.com Phone: (646) 453-8903

SOURCE The Gross Law Firm